结肠息肉监测能否改善患者结局?
结肠息肉监测占所有结肠镜检查的25%,但监测降低结直肠癌(CRC)发病率或死亡率的证据薄弱。基线病变生物学与基线检查质量是导致结肠镜后CRC的两个主要因素;新证据显示基线结肠镜发现与CRC发病或死亡风险强相关,为更新监测推荐提供依据。
要点
- 结肠息肉监测占所有结肠镜检查的25%。
- 监测降低CRC发病率或死亡率的证据薄弱。
- 基线结肠镜发现与CRC发病或死亡风险强相关。
核心结论
- 监测降低CRC发病率或死亡率的证据薄弱。
- 基线结肠镜发现与CRC发病或死亡风险强相关,为更新监测推荐提供依据。
- 基线检查质量是结肠镜后CRC的重要预测因素。
研究设计与样本
- 原文未报告研究设计与样本量。
主要发现
- 结肠息肉监测占所有结肠镜检查的25%。
- 基线病变生物学和基线检查质量是结肠镜后CRC的两个主要因素。
- 既往监测推荐主要基于腺瘤患者进展为进展期腺瘤的可能性,后者为CRC的替代指标。
临床怎么用
- 临床应重视基线结肠镜发现与基线检查质量对监测决策的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colon polyp surveillance now accounts for 25% of all colonoscopies performed. The evidence that colonoscopy surveillance reduces colorectal cancer (CRC) incidence or mortality is weak. The biology of the baseline lesions and quality of the baseline exam are two primary factors contributing to post-colonoscopy CRC. Prior recommendations for surveillance were based largely on the likelihood that patients with adenomas would develop advanced adenomas, a surrogate for CRC. There is now evidence that baseline colonoscopy findings are strongly associated with the risk of incidence or death from CRC. This evidence provides a basis for updated evidence-based recommendations for surveillance. In addition, there is also growing evidence that the quality of the baseline exam is an important predictor of the likelihood of developing post-colonoscopy CRC.
引用
- Lieberman D, Gupta S. Does Colon Polyp Surveillance Improve Patient Outcomes? Gastroenterology. 2019. PMID: 31614123. doi:10.1053/j.gastro.2019.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。